M. Toida et al., CHARACTERIZATION OF CELLS CONTAINING FACTOR-XIII SUBUNIT A IN BENIGN AND MALIGNANT BUCCAL LESIONS, Histochemical Journal, 27(6), 1995, pp. 449-456
In the present study, the distribution pattern and characteristics of
cells containing Factor XIII subunit a (FXIII A) have been studied in
benign and malignant lesions of human buccal mucosa. Tissues from four
irritation fibromas and three squamous cell carcinomas were studied b
y means of double immunofluorescent staining techniques in which the d
etection of FXIII A was combined with a reaction with CD14 (recognizin
g a monocyte/macrophage differentiation marker antigen), Mac 387 (reac
ting with a special subset of macrophages), anti-HLA-DR, Ki-M7 (labell
ing phagocytosing macrophages) or Ki-67 (visualizing a nuclear antigen
associated with cell proliferation) monoclonal antibodies. FXIII A wa
s detected in cells of the connective tissue stroma in both benign and
malignant buccal lesions. The number of these FXIII A-reactive cells
(FXIII A(+) cells) increased considerably in the tumour tissues, in pa
rticular in those surrounding tumour cell clusters. FXIII A(+) cells s
cattered in the fibromatous tissues were spindle-shaped, whereas in th
e tumour stroma, large stellate cells predominated, and round cells we
re likewise labelled around blood vessels. FXIII A(+) cells were label
led with CD14 and Ki-M7 in both fibromatous and tumoural buccal mucosa
; however, they failed to show any reaction with Ki-67. FXIII A(+) cel
ls accumulated in the tumour stroma reacted for HLA-DR as well. These
results indicate that in both the benign and malignant buccal lesions
FXIII A is contained in a subpopulation of tissue macrophages, which r
epresents a monocyte-derived (CD14(+)) and phagocytosing (Ki-M7(+)) ce
ll population. The accumulation of the FXIII A(+) cells in the tumour
stroma is believed to be a result of direct migration from the circula
ting blood. The FXIII A(+) cells of the tumour stroma may be actively
involved in both antigen presentation and matrix remodelling during tu
mour progression.